Abstract
The way lymph node metastases and cancer in general are looked upon has changed significantly over the years. From the middle of the 20th century cancer was thought of more and more as a disease already disseminated at the time of presentation, and tumor positive lymph nodes were considered metastatic disease. Lymph node dissection was accordingly not considered curative anymore, but turned into a mere staging procedure. Lymph node metastases had become “indicators, but not governors of survival”1.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cady B. Lymph node metastases:indicators, but not governors of survival. Arch Surg 1984; 119: 1067–72.
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen K-B, Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55.
Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CML, Paradis M, Coldman AJ, Olivotto IA. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62.
Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, Van Houwelingen HC, Van derVelde CJH. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer:an international analysis of 1411 patients. Eur J Surg Oncol 1999; 25: 368–74.
Balch CM, Soong S-j, Bartolluci A, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Ross Ml, Jewell WR, Mihm MC, Barnhill RL, Wanebo HJ. Efficacy of an elective regional lymph node dissection of I to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996; 224: 255–63.
Akoh JA, Macintyre IMC. Improving survival in gastric cancer:review of 5-year survival rates in english language publications from 1970. Br J Surg 1992; 79: 293–9.
Bonenkamp JJ, Hermans J, Sasako M, Welvaart K, Plukker JTM, Van Elk P, Obertop H, Gouma DJ, Taat CW, Van Lanschot J, Meyer S, De Graaf PW, Von Meyenfeldt MF, Tilanus H, Van de Velde CJH (for the Dutch gastric cancer group). Randomised comparison of morbidity after DI and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745–8.
Bonenkamp JJ, Hermans J, Sasako M, Van de Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340 (12): 908–14.
Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845–57.
Akiyama H. Surgery for Cancer of the Esophagus. Williams and Wilkins 1990, Baltimore, USA
Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy:clinical experience and refinements. Ann Surg 1999; 230: 392–403.
Orringer MB. Transhiatal oesophagectomy. In:Jamieson GC, Debas HT eds. Surgery of the Upper Gastrointestinal Tract. Chapman & Hall Medical, London 1994.
Lewis I. The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growths of the middle third. Br J Surg 1946: 34: 18–31.
Tanner NC. The present position of carcinoma of the oesophagus. Postgrad Med J 1947; 23: 109–39.
Hagen JA, DeMeester TR. En bloc oesophagectomy for cancer of the distal oesophagus, cardia and proximal stomach. In:Jamieson GC, Debas HT eds. Surgery of the upper gastrointestinal tract. Chapman & Hall Medical 1994, London, England.
Akiyama H, Tsumumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 3: 364–73.
Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 1998; 186: 306–12.
Nigro JJ, Hagen JA, DeMeester TR, DeMeester SR, Peters JH, Oberg S, Theisen J, Kiyabu M, Crookes PF, Bremner CG. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall:implications for therapy. J Thorac Cardiovasc Surg 1999; 17: 16–25.
Sugimachi K, Ikebe M, Kitamura K, Toh Y, Matsuda H, Kuwano H. Long-term results of esophagectomy for early esophageal carcinoma. Hepato- Gastroenterol 1993; 40: 203–6.
Van Sandick JW, Van Lanschot JJB, Ten Kate FJW, Offerhaus GJA, Fockens P, Tytgat GNJ, Obertop H. Pathology of early invasive adenocarcinoma of the oesophagus or oesophagogastric junction:implications for therapeutic decision making. Cancer, in press.
Nigro JJ, Hagen JA, DeMeester TR, DeMeester SR, Theisen J, Peters JH, Miyaby M. Occult esophageal adenocarcinoma. Extent of disease and implications for effective therapy. Ann Surg 1999; 230: 433–40.
Clark GWB, Peters JH, Ireland AP, Ehsan A, Hagen JA, Liyabu MT, Bremner CG, DeMeester TM. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994; 58: 646–54.
Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Hatakeyama K, Muto T. Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 1994; 74: 4–11.
Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M. Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg 1998; 187: 23845.
Nigro JJ, DeMeester SR, Hagen JA, DeMeesrter TR, Peters JH, Kiyabu M, Campos GMR, Oberg S, Gastal O, Crookes PF, Bremner CG. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999; 117: 960–8.
Matsubara T, Ueda M, Yanagida O, Nakajima T, -Nishi M. How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg 1994; 107: 1073–8.
Altorki NK, Skinner DB. Occult cervical nodal metastasis in esophageal cancer:preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg 1997: 113; 540–4.
Hulscher JBF, Van Sandick JW, Tijssen JGP, Obertop H, Van Lanschot JJB. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg, in press
Siewert JR, Fink U, Beckurts KTE, Roder JD. Surgery of squamous cell carcinoma of the esophagus. Ann Oncol 1994:; (Suppl.3):S I -S7.
Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T. tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy of pTNM classification. J Thorac Cardiovasc Surg 1996; 111: 85–95.
Abe S, Tachibana M, Shiraishi M, Nakamura T. Lymph node metastasis in resectable esophageal cancer. J Thorac Cardiovasc Surg 1990; 100: 287–91
Van Sandick JW, Van Lanschot JJB, Fockens P, Obertop H. Peri-operative complications and prognostic factors after transhiatal oesophageal resection without thoracotomy for cancer. Thesis, 1999, University of Amsterdam.
Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410–3.
lzbicki JB, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337: 118–94.
Bonavina L, Ferrero S, Midolo V, Buffa R, Cesana B, Peracchia A. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction. J Gastrointest Surg 1999; 3: 468–76.
Paget S. The distribution of secondary grwoths in cancer of the breast. Lancet 1889; 1: 571–3.
Chu KM, Law SY, Fok M, Wong J. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997; 174: 320–4.
Tilanus 14W, Hop WCJ, Langenhorst BLAM, Van Lanschot JJB. Esophagectomy with or without thoracotomy. J Thorac Cardiovasc Surg 1993; 105: 898–903.
Gupta NM. Ocsophagectomy without thoracotomy:first 250 patients. Eur J Surg 1996; 162: 455–61.
Lieberman-Meffert DMI, luescher U, Neff U, Ruedi TP, Allgower M. Esophagectomy without thoracotomy:is there a risk of intramediastinal bleeding? Ann Surg 1987; 206: 84–92.
Daniel TM, Fleisher KJ, Flanagan TL, Tribble CG, Kron IL. Transhiatal esophagectomy:a safe alternative for selected patients. Ann Thorac Surg 1992; 54: 686–90.
Van Sandick JW, Van Lanschot JJB, Tilanus HW, Wijnhoven B, Hennipman A, Obertop H. Transhiatal esophagectomy versus transthoracic esophagectomy with two-fields lymphadenectomy. Interim results of a randomized study. Can J Gastroenterol 1998; 12 (B): 48B.
Goldminc M, Maddern G, LePrise E, Meunier B, Campion JP, Launois B. Oesophagectomy by transhiatal approach or thoracotomy:a prospective randomized trial. Br J Surg 1993; 80: 367–70.
Jacobi CA, Zieren HU, Müller M, Pichlmaier H. Surgical therapy of esophageal carcinoma:the influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothoracic Surg 1997; 11: 32–7.
Lerut T, DeLeyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583–90.
Paç M, Basoglu A, Koçak H, et al. Transhiatal versus transthoracic esophagectomy for esophageal cancer. J Thorac Cardiovasc Surg 1993; 106: 205–9.
Stark SP, Romberg MS, Pierce GE et al. Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. Am J Surg 1996: 172; 478–82.
Gluch L, Smith RC, Bambach CP, Brown AR. Comparison of outcomes following transhiatal or Ivor Lewis esophageactomy for esophageal carcinoma. World J Surg 1999; 23: 271–6.
Horstmann O, Verreet PR, Becker H, Ohmann C, Röher HD. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer. Eur J Surg 1995; 161: 557–67.
Moon MR, Schulte WJ, Haasler GB, Condon RE. Transhiatal and transthoracic esophagectomy for adenocarcinoma of the esophagus. Arch Surg 1992; 127: 951–5.
Putnam JB, Suell DM, McMurtey MJ, et al. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 1994; 7: 319–25.
Fok M, Law S, Stipa F, Cheng S, Wong J. A comparison of transhiatal and transthoracic resection for oesophageal carcinoma. Endoscopy 1993; 25 (Suppl.) 660–3.
Jauch KW, Bacha EA, Denecke H, Anthuber M, Schildberg FW. Esophageal carcinoma:prognostic features and comparison between blunt transhiatal dissection and transthoracic resection. Eur J Surg Oncol 1992; 18: 553–62.
McLarty AJ, Deschamps C, Trastek VF, Allen MS, Pairolero PC, Harmsen WS. Esophageal resection for cancer of the esophagus:long-term function and quality of life. Ann Thorac Surg 1997; 63: 1568–72.
Hulscher JBF, Van Sandick JW, DeVriese PP, Van Lanschot JJB, Obertop H. Vocal cord paralysis after subtotal oesophagectomy. Br J Surg, 1999; 86: 15836.
Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma:I. a critical review of surgery. Br J Surg 1980; 67: 381–90.
Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital’s annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg 1998; 2: 186–92.
Hagen JA, Peters JH, DeMeester TR. Superiority of extended en bloc esophagectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993; 106: 850–9.
Junginger T, Dutkowski P. Selective approach to the treatment of oesophageal cancer. Br J Surg 1996; 83: 1473–7.
Gertsch P, Vauthey JN, Lustenberger AA, Friedlander-Klar. Long-term results of transhiatal esophagectomy for esophageal carcinoma. Cancer 1993; 72: 2312–9.
Bolton JS, Ochsner JL, Abdoh A. Surgical management of esophageal cancer:a decade of change. Ann Surg 1994; 219: 475–80.
Van Sandick JW, Gisbertz SS, Ten Berge IJM, Van der Pouw Kraan TCTM, Out TA, Boermeester MA, Van Lanschot JJB. Relations between preoperative T cell response profile and infectious complication risk in patients undergoing transhiatal or transthoracic oesophagectomy for cancer. In:Van Sandick JW. Early detection and surgical treatment of adenocarcinoma of the oesophagus or oesophagogastric junction. Thesis 1999, University of Amsterdam.
Bonavina L. Early oesophageal cancer:results of a European multicentre survey. Br J Surg 1995; 82: 98101.
Van Lanschot JJB, Tilanus HW, Voormolen MHJ, Van Deelen RAJ. Recurrence pattern of oesophageal carcinoma after limited resection does not support wide local excision with extensive lymph node dissection. Br J Surg 1994; 81: 1320–3.
Hulscher JBF, Van Sandick JW, Tijssen JGP, Obertop H, Van Lanschot JJB. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg, in press.
Morita M, Kuwano H, Ohno S, Furusawa M, Sugimachi K. Characteristics and sequence of the recurrent patterns after curative esophagectomy for squamous cell carcinoma. Surgery 1994; 116: 1–7.
Dresner SM, Wayman J, Shenfine J, Harris A, Hayes N, Griffin SM. The pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Gut 1999; 45 (Suppl V): A235.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hulscher, J.B.F., van Lanschot, J.J.B. (2001). Resection of Esophageal Carcinoma: The Role of Lymph Node Dissection. In: Tilanus, H.W., Attwood, S.E.A. (eds) Barrett’s Esophagus. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0829-6_27
Download citation
DOI: https://doi.org/10.1007/978-94-017-0829-6_27
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5860-7
Online ISBN: 978-94-017-0829-6
eBook Packages: Springer Book Archive